How has Covid-19 impacted the pharma industry in general and what are the emerging challenges ? The Covid-19 pandemic has shown us how quickly a health crisis can become an overwhelming challenge and disrupt work and personal life. The important lesson the pharma industry has learnt is that much more can be achieved through collaboration between companies in the private sector, and even between the private and public sectors than we believed possible. This situation has also raised people’s expectations from the research community and pharma industry, and there is a greater need now for quick results without any compromise on efficacy and patient safety. This is where bioinformatics and biostatistics will play a crucial role. Bioinformatics and biostatistics tools can help analyse and mine a large quantum of data, so researchers can take correct decisions and minimize uncertainty.